Venaxis Inc (APPY.OQ) Quote| Reuters.com
Edition:
United States

Venaxis Inc (APPY.OQ)

APPY.OQ on NASDAQ Stock Exchange Capital Market

3.50USD
24 Jun 2016
Change (% chg)

$-0.10 (-2.78%)
Prev Close
$3.60
Open
$3.52
Day's High
$3.56
Day's Low
$3.38
Volume
1,309
Avg. Vol
10,765
52-wk High
$6.65
52-wk Low
$1.60

APPY.OQ

Chart for APPY.OQ

About

Venaxis, Inc. (Venaxis) is an in vitro diagnostic company that is focused on commercializing its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children, adolescent and young adults. The Company's test, the APPY1 Test, is a blood test panel for aiding in identifying... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $13.49
Shares Outstanding(Mil.): 3.88
Dividend: --
Yield (%): --

Financials

  APPY.OQ Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -1.55 -- --
ROI: -28.00 -5.72 14.23
ROE: -31.14 -4.83 15.46

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $33.97 -0.62
Johnson & Johnson (JNJ.N) $115.63 -1.75
Abbott Laboratories (ABT.N) $37.91 -1.72
Bayer AG (BAYGn.DE) €87.64 -5.53
Bayer AG (BAYE.F) -- --
Eli Lilly and Co (LLY.N) $74.33 +0.39

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.